Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells.

Yan H, Zhu S, Song C, Liu N, Kang J.

Cell Signal. 2012 Apr;24(4):961-8. doi: 10.1016/j.cellsig.2011.12.019. Epub 2011 Dec 30.

PMID:
22234345
2.

Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.

Shen Z, Seppänen H, Kauttu T, Vainionpää S, Ye Y, Wang S, Mustonen H, Puolakkainen P.

J Interferon Cytokine Res. 2013 Aug;33(8):428-33. doi: 10.1089/jir.2012.0046. Epub 2013 May 7.

3.

Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.

Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E.

Clin Cancer Res. 2006 Jan 15;12(2):405-10.

4.

Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.

Yao Y, Zebboudj AF, Shao E, Perez M, Boström K.

J Biol Chem. 2006 Nov 10;281(45):33921-30. Epub 2006 Sep 1.

5.

BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway.

Stewart A, Guan H, Yang K.

J Cell Physiol. 2010 Jun;223(3):658-66. doi: 10.1002/jcp.22064.

PMID:
20143330
6.

Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.

Candia AF, Watabe T, Hawley SH, Onichtchouk D, Zhang Y, Derynck R, Niehrs C, Cho KW.

Development. 1997 Nov;124(22):4467-80.

7.

TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.

Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P.

J Cell Sci. 1999 Dec;112 ( Pt 24):4557-68.

8.
9.

MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.

To-Ho KW, Cheung HW, Ling MT, Wong YC, Wang X.

Oncogene. 2008 Jan 10;27(3):347-57. Epub 2007 Jul 9.

PMID:
17621272
11.

SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1.

Raju GP, Dimova N, Klein PS, Huang HC.

J Biol Chem. 2003 Jan 3;278(1):428-37. Epub 2002 Oct 21.

12.

Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.

Lo YL, Yu JC, Chen ST, Hsu GC, Mau YC, Yang SL, Wu PE, Shen CY.

Carcinogenesis. 2007 May;28(5):1079-86. Epub 2007 Jan 8.

PMID:
17210994
13.

A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.

Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T.

J Biol Chem. 1997 Aug 29;272(35):22046-52.

14.

Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.

Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL.

J Cancer Res Clin Oncol. 2005 Nov;131(11):741-50. Epub 2005 Nov 1.

PMID:
16136355
15.

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC.

Breast Cancer Res Treat. 2002 Jun;74(3):255-69.

PMID:
12206515
16.

BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.

Miyazaki H, Watabe T, Kitamura T, Miyazono K.

Oncogene. 2004 Dec 16;23(58):9326-35.

PMID:
15531927
17.

Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.

de Jong DS, van Zoelen EJ, Bauerschmidt S, Olijve W, Steegenga WT.

J Bone Miner Res. 2002 Dec;17(12):2119-29.

18.

SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.

Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, Miyazawa K.

Cancer Res. 2003 Nov 15;63(22):7791-8.

19.
20.

Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.

Bondestam J, Kaivo-oja N, Kallio J, Groome N, Hydén-Granskog C, Fujii M, Moustakas A, Jalanko A, ten Dijke P, Ritvos O.

Mol Cell Endocrinol. 2002 Sep 30;195(1-2):79-88.

PMID:
12354674

Supplemental Content

Support Center